At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 31, 2026 at 20:00 ET
Two Natera insiders sold shares in a recent 7-day window, including the President of Clinical Diagnostics and the Chief Legal Officer, realizing $271K in open-market sales. The Executive Chairman also exercised derivatives but those were non-cash transactions with minimal economic impact.
- President of Clinical Diagnostics, Solomon Moshkevich, sold 1,048 shares for $211K at ~$201/share
- Chief Legal Officer, Daniel Rabinowitz, sold 300 shares for $60K at ~$201/share
- Executive Chairman Matthew Rabinowitz exercised derivatives for 83,416 shares, but $399K of value was non-cash and tax-related
- Total open-market selling by insiders: $271K
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access